Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Numerous cancer drugs have received accelerated approval from the US Food and Drug Administration (FDA) based on clinical trial outcomes that are otherwise not acceptable for traditional FDA approval; the accelerated approval process allows outcomes based on surrogate measures that are only reasonab...

Full description

Saved in:
Bibliographic Details
Published in:JAMA internal medicine Vol. 181; no. 4; p. 490
Main Authors: Cherla, Avi, Naci, Huseyin, Kesselheim, Aaron S, Gyawali, Bishal, Mossialos, Elias
Format: Journal Article
Language:English
Published: United States 01.04.2021
Subjects:
Antineoplastic Agents - economics
Cohort Studies
Drug Approval
Humans
Insurance Coverage
State Medicine
ISSN:2168-6114, 2168-6114
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first